
The New Era of Obesity Medication: What’s Changing in Cardiovascular Care Guest: Kyla Lara-Breitinger, M.D., M.S. Host: Stephen Kopecky, M.D. GLP-1 receptor agonists are changing the way clinicians think about obesity—not simply as a weight issue, but as a cardiometabolic disease with important cardiovascular…



























